JacobGlassMD

PubMed

• 2 citations
  Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.
  Andrew J Dunbar, Robert L Bowman, Young C Park, Kavi O'Connor, Franco Izzo, Robert M Myers, Abdul Karzai, Zach Zaroogian, Won Jun Kim, Ines Fernandez-Maestre, Michael ...> ;Cancer Discovery. 2024 Jan 12
• Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia.
  Evan Atchley, Taylor M Weis, Andriy Derkach, Pallavi K Galera, Wenbin Xiao, Jacob Glass, Susan DeWolf, Mikhail Roshal, Richa Shah, Sarah E Stump> ;Leukemia Research. 2023 Jul 1
• 5 citations
  Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia.
  Joseph G W McCarter, David Nemirovsky, Christopher A Famulare, Noushin Farnoud, Abhinita S Mohanty, Zoe S Stone-Molloy, Jordan Chervin, Brian J Ball, Zachary D Epstein...> ;Blood Advances. 2023 Sep 12
• 9 citations
  A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies.
  Mark A Dawson, Gautam Borthakur, Brian J P Huntly, Anastasios Karadimitris, Adrian Alegre, Aristeidis Chaidos, Dan T Vogl, Daniel A Pollyea, Faith E Davies, Gareth J M...> ;Clinical Cancer Research. 2023 Feb 16
• 2 citations
  Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia.
  Maximilian Stahl, Andriy Derkach, Noushin Farnoud, Jan Philipp Bewersdorf, Troy Robinson, Christopher Famulare, Christina Cho, Sean Devlin, Kamal Menghrajani, Minal A ...> ;American Journal of Hematology. 2023 Jan 1
• 11 citations
  PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.
  Amish J Patel, Sarah Warda, Jesper L V Maag, Rohan Misra, Miguel A Miranda-Román, Mohini R Pachai, Cindy J Lee, Dan Li, Naitao Wang, Gabriella Bayshtok, Eve Fishinevic...> ;Cancer Discovery. 2022 Sep 2
• 2 citations
  In Reply: Machine Learning and Artificial Intelligence in Neurosurgery: Status, Prospects, and Challenges.
  T Forcht Dagi, Jacob Glass, Barker Ii, F.> ;Neurosurgery. 2021 Nov 18
• 16 citations
  Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant.
  Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, Kamal Menghrajani, Susan DeWolf, Josel D. Ruiz, Doris M. Ponce, Brian C. Shaffer, Roni Tamari, James W. Young, An...> ;Leukemia & Lymphoma. 2021 Sep 3
• 16 citations
  Machine Learning and Artificial Intelligence in Neurosurgery: Status, Prospects, and Challenges.
  T Forcht Dagi, Fred G Barker, Jacob Glass> ;Neurosurgery. 2021 Jul 15
• 3 citations
  Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy.
  Jacob L. Glass, Andriy Derkach, Patrick Hilden, Amber C. King, Susan K. Seo, Katya Ahr, Ashwin Kishtagari, Ross L. Levine, Martin S. Tallman, Dan Douer> ;Leukemia Research. 2021 Mar 31
• 88 citations
  Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
  Maximilian Stahl, Kamal Menghrajani, Andriy Derkach, Alexander Chan, Wenbin Xiao, Jacob L. Glass, Amber C. King, Anthony F. Daniyan, Christopher Famulare, Bernadette M...> ;Blood Advances. 2021 Mar 9
• 6 citations
  The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy.
  Brian Ball, Meier Hsu, Sean M. Devlin, Maria E. Arcila, Mikhail Roshal, Yanming Zhang, Chris A Famulare, Aaron D Goldberg, Sheng F. Cai, Andrew Dunbar, Zachary D. Epst...> ;American Journal of Hematology. 2021 Mar 1
• 6 citations
  RAS Mutations Are Independently Associated with Decreased Overall Survival and Event-Free Survival in Patients with AML Receiving Induction Chemotherapy
  Brian Ball, Meier Hsu, Sean M. Devlin, Christopher Famulare, Sheng F. Cai, Andrew Dunbar, Zachary D. Epstein-Peterson, Kamal Menghrajani, Jacob L. Glass, Justin Taylor...> ;Blood. 2019 Nov 13
• Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia.
  Xiao, W.,Goldberg, A. D.,Famulare, C.,Devlin, S.,Nguyen, N.,Sim, S.,Kabel, C. C.,Patel, M. A.,McGovern, E.,Patel, A.,Schulman, J.,Dunbar, A.,Epstein-Peterson, Z. D.,Me...> ;Haematologica. 2018 Dec 14
• Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis.
  Pronier, E.,Bowman, R. L.,Ahn, J.,Glass, J.,Kandoth, C.,Merlinsky, T. R.,Whitfield, J. T.,Durham, B. H.,Gruet, A.,Hanasoge Somasundara, A. V.,Rampal, R.,Melnick, A.,Ko...> ;Blood. 2018 Aug 02
• LINE-1 Activity in Facultative Heterochromatin Formation during X Chromosome Inactivation.
  Chow JC, Ciaudo C, Fazzari MJ, Mise N, Servant N, Glass JL, Attreed M, Avner P, Wutz A, Barillot E, Greally JM, Voinnet O, Heard E> ;Cell. 2016-07-28
• Late-replicating heterochromatin is characterized by decreased cytosine methylation in the human genome.
  Suzuki, M., Oda, M., Ramos, M., Pascual, M., Lau, K., Stasiek, E., Agyiri, F., Thompson, R.F., Glass, J.L., Jing, Q., Sandstrom, R., Fazzari, M.J., Hansen, R.S., Stama...> ;Genome Res. 2011 Nov
• LINE-1 activity in facultative heterochromatin formation during X chromosome inactivation.
  Chow, J.C., Ciaudo, C., Fazzari, M.J., Mise, N., Servant, N., Glass, J.L., Attreed, M., Avner, P., Wutz, A., Barillot, E., Greally, J.M., Voinnet, O., Heard, E.> ;Cell. 2010 Jun 11
• CG dinucleotide periodicities recognized by the Dnmt3a-Dnmt3L complex are distinctive at retroelements and imprinted domains.
  Glass, J.L., Fazzari, M.J., Ferguson-Smith, A.C., Greally, J.M.> ;Mamm Genome. 2009-09-01
• Comparative isoschizomer profiling of cytosine methylation: the HELP assay.
  Khulan, B., Thompson, R.F., Ye, K., Fazzari, M.J., Suzuki, M., Stasiek, E., Figueroa, M.E., Glass, J.L., Chen, Q., Montagna, C., Hatchwell, E., Selzer, R.R., Richmond,...> ;Genome Res. 2006 Aug
• The complete sequence of the mucosal pathogen Ureaplasma urealyticum.
  Glass JI, Lefkowitz EJ, Glass JS, Heiner CR, Chen EY, Cassell GH> ;Nature. 2000-10-12
• Sequencing multimegabase-template DNA with BigDye terminator chemistry.
  Heiner CR, Hunkapiller KL, Chen SM, Glass JI, Chen EY> ;Genome Res.. 1998-05-01
• Different base per unit length ratios exist in single-stranded RNA and single-stranded DNA.
  Glass J, Wertz GW> ;Nucleic Acids Res.. 1980-12-11
• Directional correlation studies of anomalous water in carbonic anhydrase.
  Glass JC, Graf G> ;Nature. 1970-05-16
• Genome of the marsupial Monodelphis domestica reveals innovation in non-coding sequences.
  Mikkelsen, T. S., Wakefield, M. J., Aken, B., Amemiya, C. T., Chang, J. L., Duke, S., Garber, M., Gentles, A. J., Goodstadt, L., Heger, A., Jurka, J., Kamal, M., Mauce...> ;Nature. 2007 May 10
• Join now to see all

Abstracts/Posters

• Acute Leukemia with Lineage Infidelity: Mixed Phenotype AML Exhibits a Distinct Immunophenotype with Clinical Features Overlapping Mixed Phenotype Acute Leukemia
  Jacob L Glass, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• RAS Mutations Are Independently Associated with Decreased Overall Survival and Event-Free Survival in Patients with AML Receiving Induction Chemotherapy
  Jacob L Glass, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Leukemia Cell of Origin Influences p53 Activity and Therapeutic Sensitivity Via an Evi1-Dependent Mechanism
  Jacob L Glass, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• AML with Mutations in IDH1 and DNMT3A Exhibits a Distinct Epigenetic Signature with Poorer Overall Survival 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018